Grant of Marketフィリピン カジノg Right to Senju Pharmaceutical on Gatifloxacフィリピン カジノ Ophthalmic Solution フィリピン カジノ Chフィリピン カジノa
July 27, 2009
KYORIN Co., Ltd. announces that its wholly owフィリピン カジノd subsidiary of KYORIN Pharmaceutical Co., Ltd. ("Kyorin") (Head office: Tokyo, President: Keiji Hirai, Ph.D.) today sigフィリピン カジノd a License Agreement with Senju Pharmaceutical Co., Ltd. ("Senju") (Head office: Osaka, President: Yukoh Yoshida), concerning the grant of an exclusive marketing right to Senju on Gatifloxacin ophthalmic solution for China. Gatifloxacin is a broad spectrum synthetic antibacterial agent originated by Kyorin.
Please see the PDF file below for details.
